news - International Biopharmaceutical Industry

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Subsection - Oncology

Essential DMPK Strategies for IND Success

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

news

LeapFrog acquires majority stake in Ascent Meditech

The investment will tap into the rapidly growing $100 billion Indian healthcare market LeapFrog Investments ("LeapFrog"), the leading investor in companies that deli...

20 July 2018 news

Continue Reading →

news

Novotech partners with Asian Eye Institute

Under the terms of the MoU, the AEI will provide its professional and clinical trial expertise to Novotech managed studies. Asia-Pacific specialist CRO Novotech has...

20 July 2018 news

Continue Reading →

news

Trump’s Drug Plan Picks Up Momentum as Merck Lowers Some Prices

The Trump administration moved swiftly in the past 24 hours to implement pieces of its plan to bring down drug prices, preparing several significant steps as one of t...

20 July 2018 news Trump

Continue Reading →

news

Tecentriq misses another chance to catch Keytruda

A flurry of Phase 3 data this year from Roche's immmunotherapy Tecentriq has so far proved insufficient to erase the lead of Merck & Co.'s rival Keytruda in fi...

20 July 2018 news

Continue Reading →

news

Allergan’s eye drug stacks up against Lucentis, but wider market still iffy

Allergan on Thursday touted data from two late-stage trials that showed a drug it in-licensed from a Swiss biotech proved non-inferior to Lucentis in the treatment...

20 July 2018 news Allergan | Drug

Continue Reading →

news

Novartis picks up IL-17 inhibitor in deal worth over $1B

Novartis on Thursday inked a deal for development and commercialization rights to MOR106, an interleukin (IL)-17C inhibitor for the treatment of atopic dermatitis ...

20 July 2018 news Novartis

Continue Reading →

news

Kite and Gadeta Announce Strategic Collaboration to Advance Gamma Delta T Cell Receptor Technology for Solid Tumors

Kite, a Gilead Company (Nasdaq: GILD), and Gadeta B.V., a privately-held company focused on the discovery and development of novel cancer immunotherapies based on gam...

20 July 2018 news advance | announce

Continue Reading →

news

Immatics Enters into a Strategic Partnership with Genmab to Develop Next Generation Bispecific Cancer Immunotherapies

Immatics and Genmab to Combine Proprietary Technologies to Create Transformative Bispecific Therapies against Novel, Proprietary Tumor Targets Immatics to Receiv...

13 July 2018 news enters | genmab

Continue Reading →

news

PharmaKrysto announces licensing agreement with Rutgers University for new treatment for people with cystinuria

PharmaKrysto Ltd, a biopharmaceutical company based in Scotland, UK, announces today that it has completed an exclusive global licensing deal with Rutgers University,...

13 July 2018 news agreement | Announces

Continue Reading →

news

ANTABIO Completes € 12.5M Series A

New investors Omnes, BNP Paribas Développement and Sham Innovation Santé invest an additional €5.2M on top of the €7.3M first closing announced in October 2017 Antab...

13 July 2018 news 12.5m | ANTABIO

Continue Reading →